The Effect of Chitosan in the management of non-alcoholic fatty liver disease

Phase 3

• Conditions: on-alcoholic Fatty Liver.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20140502017522N4
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Adults (aged over 18 years old) with grade 1 to 3 non-alcoholic fatty liver disease
Not abusing alcohol (more than 10 grams for women and 20 grams for men per day)
Not having viral hepatitis, liver cancer, or other cancers
Not suffering from diabetes or untreated thyroid problems
Not suffering from mental disorders
No history of kidney disease
Willingness to cooperate

Exclusion Criteria

Taking nutritional supplements and fiber containing supplements in the 3 months before the study
History of allergy to chitosan supplements, shellfish or shrimp
Pregnancy
Being in breastfeeding period

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aspartate aminotransferase (AST). Timepoint: At the beginning of the study (before the intervention) and the end of the study (8 weeks after the intervention). Method of measurement: Enzyme-linked immuno_sorbent assay (ELISA).